SAVE IBD

SAVE IBD aims to understand how IBD medications influence the response to vaccination against SARS-CoV-2, the virus that causes COVID-19.

This study is still currently in the planning stages and is dependent on the development of a vaccine.

Once there is a vaccine available, patients from around the UK on different IBD medications will be asked if they would like to participate. Getting involved would involve taking the vaccine and then reporting back to the researchers how you respond to it.

Start date: Dependant on COVID-19 vaccine development

Lead researcher: Dr Nick Powell (Imperial College London)